sheldon l. holder
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Editors
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Associate Editors
joshua honeyman
Warren Alpert Medical School, Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
zhiwei hu
The Ohio State University
Columbus, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
arup kumar indra
Oregon State University
Corvallis, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
giulio innamorati
University of Verona
Verona, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
antoine italiano
Université de Bordeaux
Bordeaux, France
Associate Editor
Cancer Molecular Targets and Therapeutics
arun iyer
Wayne State University
Detroit, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
harikumar kb
Rajiv Gandhi Centre for Biotechnology
Thiruvananthapuram, India
Associate Editor
Cancer Molecular Targets and Therapeutics
balasubramanyam karanam
Tuskegee University
Tuskegee, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
imran khan
National Institutes of Health (NIH)
Bethesda, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
matiullah khan
AIMST University
Bedong, Malaysia
Associate Editor
Cancer Molecular Targets and Therapeutics
michael r. king
Vanderbilt University
Nashville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
antonis kirmizis
University of Cyprus
Nicosia, Cyprus
Associate Editor
Cancer Molecular Targets and Therapeutics
erik knudsen
Roswell Park Comprehensive Cancer Center, University at Buffalo
Buffalo, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
christos k. kontos
National and Kapodistrian University of Athens
Athens, Greece
Associate Editor
Cancer Molecular Targets and Therapeutics
kageaki kuribayashi
Kuribayashi Clinic
Oita City, Japan
Associate Editor
Cancer Molecular Targets and Therapeutics